A national long-read sequencing study on chromosomal rearrangements uncovers hidden complexities.


Journal

Genome research
ISSN: 1549-5469
Titre abrégé: Genome Res
Pays: United States
ID NLM: 9518021

Informations de publication

Date de publication:
29 Oct 2024
Historique:
received: 25 04 2024
accepted: 25 09 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 29 10 2024
Statut: aheadofprint

Résumé

Clinical genetic laboratories often require a comprehensive analysis of chromosomal rearrangements/structural variants (SVs), from large events like translocations and inversions to supernumerary ring/marker chromosomes and small deletions or duplications. Understanding the complexity of these events and their clinical consequences requires pinpointing breakpoint junctions and resolving the derivative chromosome structure. This task often surpasses the capabilities of short-read sequencing technologies. In contrast, long-read sequencing techniques present a compelling alternative for clinical diagnostics. Here, Genomic Medicine Sweden-Rare Diseases has explored the utility of HiFi Revio long-read genome sequencing (lrGS) for digital karyotyping of SVs nationwide. The 16 samples from 13 families were collected from all Swedish healthcare regions. Prior investigations had identified 16 SVs, ranging from simple to complex rearrangements, including inversions, translocations, and copy number variants. We have established a national pipeline and a shared variant database for variant calling and filtering. Using lrGS, 14 of the 16 known SVs are detected. Of these, 13 are mapped at nucleotide resolution, and one complex rearrangement is only visible by read depth. Two Chromosome 21 rearrangements, one mosaic, remain undetected. Average read lengths are 8.3-18.8 kb with coverage exceeding 20× for all samples. De novo assembly results in a limited number of phased contigs per individual (N50 6-86 Mb), enabling direct characterization of the chromosomal rearrangements. In a national pilot study, we demonstrate the utility of HiFi Revio lrGS for analyzing chromosomal rearrangements. Based on our results, we propose a 5-year plan to expand lrGS use for rare disease diagnostics in Sweden.

Identifiants

pubmed: 39472022
pii: gr.279510.124
doi: 10.1101/gr.279510.124
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Eisfeldt et al.; Published by Cold Spring Harbor Laboratory Press.

Auteurs

Jesper Eisfeldt (J)

Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
Department of Clinical Genetics and Genomics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Science for Life Laboratory, Karolinska Institutet Science Park, 171 65 Solna, Sweden.

Adam Ameur (A)

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.
Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden.

Felix Lenner (F)

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.
Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden.

Esmee Ten Berk de Boer (E)

Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
Department of Clinical Genetics and Genomics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
Science for Life Laboratory, Karolinska Institutet Science Park, 171 65 Solna, Sweden.

Marlene Ek (M)

Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
Department of Clinical Genetics and Genomics, Karolinska University Hospital, 171 76 Stockholm, Sweden.

Josephine Wincent (J)

Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
Department of Clinical Genetics and Genomics, Karolinska University Hospital, 171 76 Stockholm, Sweden.

Raquel Vaz (R)

Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.

Jesper Ottosson (J)

Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, 413 90 Gothenburg, Sweden.

Tord Jonson (T)

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, 221 84 Lund, Sweden.
Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Region Skåne, 223 62 Lund, Sweden.

Sofie Ivarsson (S)

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, 221 84 Lund, Sweden.
Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Region Skåne, 223 62 Lund, Sweden.

Sofia Thunström (S)

Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, 413 90 Gothenburg, Sweden.

Alexandra Topa (A)

Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, 413 90 Gothenburg, Sweden.

Simon Stenberg (S)

Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, 413 90 Gothenburg, Sweden.

Anna Rohlin (A)

Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, 413 90 Gothenburg, Sweden.
Department of Laboratory Medicine, Institute for Biomedicine, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.

Anna Sandestig (A)

Department of Clinical Genetics, Linköping University Hospital, 581 85 Linköping, Sweden.

Margareta Nordling (M)

Department of Clinical Genetics, Linköping University Hospital, 581 85 Linköping, Sweden.
Division of Cell and Neurobiology, Department of Biomedical and Clinical Sciences, Linköping University, 581 83 Linköping, Sweden.

Pia Palmebäck (P)

Department of Clinical Genetics, Linköping University Hospital, 581 85 Linköping, Sweden.

Magnus Burstedt (M)

Department of Medical Bioscience, Medical and Clinical Genetics, Umeå University, 901 87 Umeå, Sweden.

Frida Nordin (F)

Department of Pharmacology and Clinical Neurosciences, Umeå University, 901 87 Umeå, Sweden.

Eva-Lena Stattin (EL)

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.

Maria Sobol (M)

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.

Panagiotis Baliakas (P)

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.
Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden.

Marie-Louise Bondeson (ML)

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.
Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden.

Ida Höijer (I)

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.
Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden.

Kristine Bilgrav Saether (KB)

Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
Science for Life Laboratory, Karolinska Institutet Science Park, 171 65 Solna, Sweden.

Lovisa Lovmar (L)

Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, 413 90 Gothenburg, Sweden.

Hans Ehrencrona (H)

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, 221 84 Lund, Sweden.
Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Region Skåne, 223 62 Lund, Sweden.

Malin Melin (M)

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.
Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden.

Lars Feuk (L)

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden; anna.lindstrand@ki.se lars.feuk@igp.uu.se.
Science for Life Laboratory, Uppsala University, 752 37 Uppsala, Sweden.

Anna Lindstrand (A)

Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden; anna.lindstrand@ki.se lars.feuk@igp.uu.se.
Department of Clinical Genetics and Genomics, Karolinska University Hospital, 171 76 Stockholm, Sweden.

Classifications MeSH